Amir Nashat
CIK 1575843 · last filed 2025-09-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$76.23M
Companies
10
Total Filings
81
Lifetime Open-Market Net
-$16.51M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CAMP | Director | 197,661 | $4.19 | $828.2K | $12.00M | 3 | 2025-09-11 |
| Morphic Holding, Inc. (MORF) Delisted | Director | 130,298 | $56.99 | $7.43M | -$8.69M | 9 | 2024-06-05 |
| SRRK | Director | 1,689,555 | $44.18 | $74.64M | $7.87M | 13 | 2024-05-13 |
| Metacrine, Inc. (MTCR) Delisted | Director | 2,499,210 | $0.49 | $1.24M | $2.99M | 3 | 2022-09-06 |
| SYRS | Director | 22,167 | $0.00 | $9 | $5.00M | 9 | 2022-06-02 |
| FATE | Director | 11,333 | $2.06 | $23.3K | -$17.96M | 21 | 2019-08-02 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Director | 52,156 | $0.88 | $46.0K | -$1.92M | 8 | 2019-06-18 |
| LIFE | Director | 46,950 | $15.61 | $732.9K | $0 | 6 | 2018-05-17 |
| DNIB UNWIND, INC. (BIND) Delisted | Director | — | — | — | $0 | 1 | 2015-06-10 |
| Receptos, Inc. (RCPT) Delisted | Director | 46,923 | — | — | -$15.80M | 7 | 2013-12-10 |
Recent Filings · Page 6 of 9
81 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-15 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2018-05-31 | SRRK | Mixed | +2,832,706 | $2.00M | EDGAR |
| 2018-05-17 | LIFE | Grant (A) | — | $0 | EDGAR |
| 2018-05-04 | FATE | Grant (A) | — | $0 | EDGAR |
| 2017-09-28 | Cartesian Therapeutics, Inc. (SELB) Delisted | Sell (S) | −70,226 | -$1.33M | EDGAR |
| 2017-09-26 | Cartesian Therapeutics, Inc. (SELB) Delisted | Sell (S) | −79,211 | -$1.52M | EDGAR |
| 2017-09-22 | Cartesian Therapeutics, Inc. (SELB) Delisted | Sell (S) | −147,187 | -$2.93M | EDGAR |
| 2017-09-22 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2017-06-20 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-12 | SYRS | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.